Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%

Cornerstones of Cost Management (Cornerstones Series)
4th Edition
ISBN:9781305970663
Author:Don R. Hansen, Maryanne M. Mowen
Publisher:Don R. Hansen, Maryanne M. Mowen
Chapter10: Decentralization: Responsibility Accounting, Performance Evaluation, And Transfer Pricing
Section: Chapter Questions
Problem 11E: Xenold, Inc., manufactures and sells cooktops and ovens through three divisions: Home, Restaurant,...
icon
Related questions
Question
Pharma Inc. has two product lines organized
as divisions (Pain Reliever and Weight Loser)
and spends heavily on research and
development (R&D) activities. The following
information is related to Pharma Inc's second
year of operations.
Pain
Reliever
$450,000 $300,000
Weight
Loser
R&D expenditures
(second year)
After-tax income
Current liabilities
Divisional investment 1,365,000 982,000
Cost of capital
In the first year, Pain Reliever spent $300,000
on R&D, while Weight Loser spent $150,000.
Pharma Inc. estimates that R&D expenditures
have a three-year life to be amortized
according to the following schedule: 1/6 in the
year incurred, 1/3 in the next two years, and
1/6 in the fourth year after the initial
spending.
Required:
Calculate EVA for the two divisions of Pharma
Inc. for its second year of operations.
275,000
584,000
$210,000
397,000
23%
23%
Transcribed Image Text:Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Ratio Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Cornerstones of Cost Management (Cornerstones Ser…
Cornerstones of Cost Management (Cornerstones Ser…
Accounting
ISBN:
9781305970663
Author:
Don R. Hansen, Maryanne M. Mowen
Publisher:
Cengage Learning
Principles of Accounting Volume 2
Principles of Accounting Volume 2
Accounting
ISBN:
9781947172609
Author:
OpenStax
Publisher:
OpenStax College
Financial And Managerial Accounting
Financial And Managerial Accounting
Accounting
ISBN:
9781337902663
Author:
WARREN, Carl S.
Publisher:
Cengage Learning,
Managerial Accounting
Managerial Accounting
Accounting
ISBN:
9781337912020
Author:
Carl Warren, Ph.d. Cma William B. Tayler
Publisher:
South-Western College Pub